研究・業績

業績

原著論文

英文

  • Mortality Risk Stratification Using Cluster Analysis in Patients With Myositis-Associated Interstitial Lung Disease Receiving Initial Triple-Combination Therapy
    Gono T, Masui K, Sato S, Kuwana M; Multicenter Retrospective Cohort of Japanese Patients with Myositis-Associated ILD (JAMI) Investigators.
    Frontiers in Medicine. 2022 May 2022 Volume 9 doi: 10.3389/fmed.2022.883699.
  • Reversible improvement of arterial stenosis and wall thickness in Takayasu arteritis through treatment with tocilizumab
    Nogi S, Yano Y, Kodama K, Tsuno H, Ogihara H, Kawakami M, Ohmori T, Sato S, Matsui T.
    AIM Clinical Cases. 2022;1:e220705. doi:10.7326/aimcc.2022.0705

学会発表

国際

  • Detection of the Novel Autoantibodies Against Transcription Factor Sp4 Is Related with Low Risk of Cancer in Idiopathic Inflammatory Myopathy Patients.
    Hosono Y, Kojima A, Ishii A, Sugiyama M, Izumi Y, Sasaki N, Yamada C, Sato S.
    American College of Rheumatology Convergence 2022. 2022.11

ページトップへ戻る